Porfidia, Angelo
 Distribuzione geografica
Continente #
NA - Nord America 2.255
AS - Asia 1.514
EU - Europa 1.191
SA - Sud America 330
AF - Africa 43
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.339
Nazione #
US - Stati Uniti d'America 2.195
SG - Singapore 733
CN - Cina 298
BR - Brasile 266
SE - Svezia 218
IT - Italia 217
VN - Vietnam 192
PL - Polonia 162
DE - Germania 155
FR - Francia 125
IE - Irlanda 61
GB - Regno Unito 56
IN - India 50
ID - Indonesia 46
FI - Finlandia 43
JP - Giappone 43
UA - Ucraina 39
HK - Hong Kong 37
AR - Argentina 30
CA - Canada 30
RU - Federazione Russa 26
MX - Messico 21
ZA - Sudafrica 21
BD - Bangladesh 20
IQ - Iraq 18
ES - Italia 14
NL - Olanda 14
BE - Belgio 13
AT - Austria 12
KR - Corea 11
PK - Pakistan 11
TR - Turchia 11
EC - Ecuador 10
GR - Grecia 7
LT - Lituania 7
MA - Marocco 7
CO - Colombia 6
UZ - Uzbekistan 6
VE - Venezuela 6
IR - Iran 5
PE - Perù 5
PY - Paraguay 5
GE - Georgia 4
JO - Giordania 4
AL - Albania 3
AU - Australia 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
ET - Etiopia 3
JM - Giamaica 3
KE - Kenya 3
MY - Malesia 3
NP - Nepal 3
RO - Romania 3
SA - Arabia Saudita 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
BH - Bahrain 2
CI - Costa d'Avorio 2
EU - Europa 2
HU - Ungheria 2
PH - Filippine 2
AZ - Azerbaigian 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CG - Congo 1
CL - Cile 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EG - Egitto 1
HR - Croazia 1
IL - Israele 1
IS - Islanda 1
KZ - Kazakistan 1
LB - Libano 1
MN - Mongolia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
TT - Trinidad e Tobago 1
Totale 5.339
Città #
Singapore 430
Chandler 274
Ashburn 263
Dallas 254
San Jose 193
Warsaw 158
Fairfield 108
Beijing 77
Ho Chi Minh City 70
Dublin 60
Rome 60
Woodbridge 51
Wilmington 48
Los Angeles 46
Tokyo 43
Houston 42
New York 42
Hefei 39
Seattle 39
Lauterbourg 38
The Dalles 38
Ann Arbor 37
Hanoi 36
Jakarta 36
Marseille 36
Cambridge 33
Milan 33
San Mateo 31
Hong Kong 30
Boston 29
Frankfurt am Main 26
São Paulo 24
Boardman 23
Council Bluffs 22
Helsinki 22
Princeton 22
Moscow 19
Munich 17
Chicago 16
Jacksonville 16
Nanjing 15
Santa Clara 15
Brussels 13
Kent 13
London 13
Montreal 12
Da Nang 11
Johannesburg 11
Mexico City 11
Nuremberg 11
Seoul 11
Brooklyn 10
Hyderabad 10
Paris 10
Bergamo 9
Dearborn 9
Orem 9
Turku 9
Baghdad 8
Bremen 8
Buffalo 8
Cattolica 8
Denver 8
Falkenstein 8
St Louis 8
Washington 8
Zhengzhou 8
Athens 7
Augusta 7
Detroit 7
Düsseldorf 7
Fremont 7
Rio de Janeiro 7
Vienna 7
Belo Horizonte 6
Dong Ket 6
Haiphong 6
Lappeenranta 6
Lawrence 6
Prato 6
Qingdao 6
Salvador 6
San Diego 6
Toronto 6
Amsterdam 5
Busto Arsizio 5
Campinas 5
Hải Dương 5
Jiaxing 5
Lancaster 5
Manaus 5
Naples 5
Pune 5
Redwood City 5
Atlanta 4
Biên Hòa 4
Changsha 4
Columbus 4
Curitiba 4
Dhaka 4
Totale 3.338
Nome #
Microparticles Carrying Sonic Hedgehog Are Increased in Humans with Peripheral Artery Disease. 331
Differences in Clinical Presentation, Rate of Pulmonary Embolism, and Risk Factors Among Patients With Deep Vein Thrombosis in Unusual Sites. 277
Sonic hedgehog is expressed in human brain arteriovenous malformations and induces arteriovenous malformations in vivo 243
Patent foramen ovale and hypercoagulable state in the pathogenesis of acute thrombotic myocardial infarction 192
Influence of left ventricular hypertrophy on microvascular dysfunction and left ventricular remodeling after acute myocardial infarction 180
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 169
Antithrombotic Therapy in Hereditary Hemorrhagic Telangiectasia: Real-World Data from the Gemelli Hospital HHT Registry 168
Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis 161
Venous thromboembolism in COVID-19 patients 151
Reversible coronary microvascular dysfunction: a common pathogenetic mechanism in Apical Ballooning or Tako-Tsubo Syndrome 149
Pulmonary Embolism in COVID-19 Patients: Which Diagnostic Algorithm Should We Use? 145
Antithrombotic therapy and intracranial bleeding in subjects with sporadic brain arteriovenous malformations: preliminary results from a retrospective study. 143
Polycythemia vera. 133
Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience 130
Anticoagulant treatment for upper extremity deep vein thrombosis: A systematic review and meta-analysis 127
Controversies in venous thromboembolism: the unique case of isolated distal deep vein thrombosis 125
Microparticles produced by activated platelets carry a potent and functionally active angiogenic signal in subjects with crohn’s disease 125
Distribution of Cerebrovascular Phenotypes According to Variants of the ENG and ACVRL1 Genes in Subjects with Hereditary Hemorrhagic Telangiectasia 123
SARS-CoV-2 infection in a highly experienced person living with HIV 116
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 109
Clinical Correlates of In-Hospital Mortality in Patients Undergoing Inferior Vena Cava Filter Placement for Acute Deep Vein Thrombosis 108
Correction to: Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies and the lack of guidelines (Journal of Thrombosis and Thrombolysis, (2020), 50, 1, (68-71), 10.1007/s11239-020-02125-4) 106
A Single Center Retrospective Cohort Study Comparing Different Anticoagulants for the Treatment of Catheter-Related Thrombosis of the Upper Extremities in Women With Gynecologic and Breast Cancer 105
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 105
Gut dysbiosis-related thrombosis in inflammatory bowel disease: Potential disease mechanisms and emerging therapeutic strategies 104
Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies 103
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 100
Second wave of the COVID-19 pandemic: D-dimer levels are not so high anymore 98
Follow-up management of patients receiving direct oral anticoagulants 96
Acute Right Ventricular Heart Failure: An Uncommon Case of Thyrotoxicosis 95
CT pulmonary angiography for the diagnosis of pulmonary embolism in patients with COVID-19: When, why, and for whom? 94
Safety of Anticoagulant Treatment in Patients With Splanchnic Vein Thrombosis and History of Portal Hypertension–Related Bleeding 92
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis 90
Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis 89
No evidence of increased rate of thrombotic recurrences in patients with history of venous thromboembolism after vaccination for COVID-19 87
Low-Dose Rivaroxaban to Prevent Recurrences of Venous Thromboembolism in Cancer: A Real-Life Experience with a Focus on Female Patients 86
Incidence of deep vein thrombosis among non-ICU patients hospitalized for COVID-19 despite pharmacological thromboprophylaxis 86
Prevalence of pulmonary embolism on hospital admission in COVID-19 patients: Is there a role for pre-test probability scores and home treatment? 86
High-dose versus low-dose venous thromboprophylaxis in hospitalized patients with COVID-19: a systematic review and meta-analysis 84
Prophylaxis against venous thromboembolism in patients with cancer 84
Major Bleeding Risk Assessment in Patients with Cancer-Associated Venous Thromboembolism Treated with DOACs: Data from a Multicenter Cohort 79
Sonic hedgehog is expressed in human brain arteriovenous malformations and induces arteriovenous malformations in vivo 77
Major Bleeding Risk Assessment in Patients with Cancer-Associated Venous Thromboembolism Treated with DOACs: Data from a Multicenter Cohort 66
Totale 5.417
Categoria #
all - tutte 20.654
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 20.654


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202178 0 0 0 0 0 0 0 0 0 27 37 14
2021/2022356 33 20 11 23 22 15 9 49 9 20 60 85
2022/2023688 83 105 49 89 49 69 51 67 81 9 22 14
2023/2024388 20 80 18 36 27 57 43 7 8 10 26 56
2024/2025806 12 17 54 16 62 37 37 47 98 134 172 120
2025/20262.382 289 81 401 285 372 122 456 90 158 128 0 0
Totale 5.417